• New Development of FDA Regulations on Complex Generic Drugs PharmaSources/Zhulikou431
    June 03, 2021
    Since the promulgation of the Hatch-Waxman Act in 1984, in order to promote drug competition and improve public drug availability, FDA has formulated a number of policies aimed at accelerating the marketing of generic drugs.
  • Rentschler Expands Complex Antibodies Production in Germany contractpharma
    July 01, 2021
    ​Rentschler Biopharma is in the process of expanding its 2,000-liter bioreactor production capacity at its site in Germany.
  • SEA Vision Launches HarleNir contractpharma
    November 27, 2018
    Based on its Harlequin blister control system, HarleNIR is a new generation of blister inspection technology that goes beyond visible inspection to provide a chemical analysis
PharmaSources Customer Service